Venture capital firm Molten Ventures has launched a £10m buyback programme following a string of realisations from its portfolios.
In a stock exchange notice today (26 July), the FTSE 250 firm said it had finalised the sale of its stake in the medical technology firm Endomag, yielding proceeds of around $46m slightly surpassing Molten's holding value of £35m. Molten initially invested in Endomag in 2018 and provided additional capital to support its growth in 2020, with funding also coming from Molten's EIS and VCT funds. Molten Ventures VCT launches up to £40m fundraise This exit, combined with recent proceeds from stakes in British chipmaker Graphcore and benefits platform Perkbox, takes the company to o...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
